Healthcare AI

Twitter

Facebook

Copy Link

Key Facts

Key PlayersTempus, Viz.ai, Nuance

AI AdoptionGrowing

Use CasesMedical Imaging, Clinical Decision Support, Patient Triage

Top News

Large-scale clinical trial finds generative AI improves care quality but not patient outcomes

A randomized controlled trial involving over 9,600 patients across 16 primary care clinics in Kenya tested whether generative AI can improve patient-level outcomes in real-world settings. The AI Consult tool improved clinical documentation and decision-making quality while reducing antibiotic costs, but showed no significant impact on short-term treatment failure rates. The findings raise important questions about measuring AI's value in primary care.

Health2 sources

Large-scale clinical trial finds generative AI improves care quality but not patient outcomes

Health2 sources

Alan raises €480M led by Prosus at €5.5 billion valuation for AI-driven prevention insurance

French insurtech Alan has secured €480M in Series G funding led by Prosus at a €5.5 billion valuation, just three months after its previous round. The Paris-based company is reshaping health insurance with AI-driven prevention, bundling health cover, care navigation, and wellbeing services into a single platform that acts before illness strikes.

Startups2 sources

Alan raises €480M led by Prosus at €5.5 billion valuation for AI-driven prevention insurance

Startups2 sources

Medical AI models expose patient data through near-perfect privacy attacks, study reveals

German researchers published findings in Nature showing AI models used for medical diagnosis can be exploited to identify patients whose data trained them. Membership inference attacks achieved near-perfect success rates for individual patients, with underrepresented groups facing disproportionately high privacy risks. The study calls for urgent changes to privacy audit standards.

Science2 sources

Medical AI models expose patient data through near-perfect privacy attacks, study reveals

Science2 sources

UC San Diego Researcher Wins $5.6M NIH Award to Build AI Tools for Disease Prevention

Natasha Martin from UC San Diego has secured a prestigious $5.6 million NIH Avant-Garde Award to develop AI tools that prevent HIV, hepatitis C, and overdose. The AMPLIFY project will create digital twins—AI-powered simulations trained on community data—to help public health departments allocate resources and design interventions tailored to people who use drugs across the United States.

Health2 sources

UC San Diego Researcher Wins $5.6M NIH Award to Build AI Tools for Disease Prevention

Health2 sources

UCLA's AI platform tracks cancer treatment responses in tumor organoids at single-cell level

Researchers at UCLA Health Jonsson Comprehensive Cancer Center developed an AI platform that combines 3D bioprinting, advanced imaging, and artificial intelligence to monitor how cancer responds to treatment. The technology analyzes thousands of patient-derived tumor organoids simultaneously, detecting rare resistant tumor populations and helping identify promising therapies for rare and hard-to-treat cancers.

Science2 sources

UCLA's AI platform tracks cancer treatment responses in tumor organoids at single-cell level

Science2 sources

Insilico Medicine and SK Biopharmaceuticals forge $2.5 billion AI drug discovery partnership

Insilico Medicine has partnered with South Korea's SK Biopharmaceuticals in a deal worth over $2.5 billion to develop AI-driven neuroimmune therapies. The collaboration combines Insilico's Pharma.AI platform with SK's clinical expertise to accelerate treatments for central nervous system disorders, marking Insilico's largest Asia-Pacific partnership to date.

Technology2 sources

Insilico Medicine and SK Biopharmaceuticals forge $2.5 billion AI drug discovery partnership

Technology2 sources

Bayer partners with Iambic Therapeutics to accelerate drug discovery using AI technology

Bayer AG has announced a collaboration with Iambic Therapeutics to develop small molecule medicines using AI-driven platforms including Enchant and NeuralPLexer technologies. The partnership aims to tackle difficult-to-drug targets and reduce the traditional 10-15 year drug discovery timeline that costs approximately $2.6 billion with over 90% clinical trial failure rates.

Technology2 sources

Bayer partners with Iambic Therapeutics to accelerate drug discovery using AI technology

Technology2 sources

Prosper AI raises $30M from a16z to automate the patient journey with AI-powered voice agents

Prosper AI has secured $30 million in Series A funding led by Andreessen Horowitz to expand its AI-driven automation platform that handles healthcare administrative tasks end-to-end. The startup's AI-powered voice agents manage appointment scheduling, insurance verification, and patient billing in a single workflow, reducing administrative costs by more than 40% while serving over 150,000 healthcare providers.

Startups4 sources

Prosper AI raises $30M from a16z to automate the patient journey with AI-powered voice agents

Startups4 sources

AI discovers hidden antibiotic candidates inside prion proteins linked to brain diseases

Researchers at the University of Pennsylvania used AI to uncover a surprising source of antibiotics: prion proteins known for causing fatal brain diseases. The deep-learning platform identified over 1,000 antimicrobial peptides called prionins, with dozens showing strong activity against drug-resistant bacteria in lab and mouse tests.

Science2 sources

AI discovers hidden antibiotic candidates inside prion proteins linked to brain diseases

Science2 sources

OpenAI upgrades ChatGPT health responses as 230 million users seek medical information weekly

OpenAI announced that GPT-5.5 Instant now delivers health responses comparable to its advanced reasoning models, with a 71% drop in factuality issues. The update comes as 230 million users turn to ChatGPT weekly for health-related queries, from understanding symptoms to preparing for doctor visits, raising questions about AI's growing role in medical information access.

Technology3 sources

OpenAI upgrades ChatGPT health responses as 230 million users seek medical information weekly

Technology3 sources

AI in medicine helps Boston Children's Hospital crack 18 rare disease diagnosis cases

Researchers at Boston Children's Hospital used OpenAI's o3 model to identify 18 new diagnoses among children with rare genetic diseases that had stumped doctors for years. The NEJM AI study analyzed 376 previously unsolved cases, demonstrating how AI tools can augment clinical expertise in navigating complex genetic data and medical literature to deliver answers to families.

Health3 sources

AI in medicine helps Boston Children's Hospital crack 18 rare disease diagnosis cases

Health3 sources

Ultrahuman M2 Live brings affordable metabolic health tracking to US consumers at $99 per month

Ultrahuman has launched M2 Live in the United States, making continuous glucose monitoring accessible to non-diabetic consumers. The platform integrates Abbott's over-the-counter Lingo CGM with AI-powered health insights, starting at $99 per month. It combines glucose data with sleep, activity, and biomarker tracking to provide comprehensive metabolic health monitoring.

Technology2 sources

Ultrahuman M2 Live brings affordable metabolic health tracking to US consumers at $99 per month

Technology2 sources

AI Deskilling Emerges as Doctors and Programmers Lose Skills Through Over-Reliance on AI Tools

New research reveals artificial intelligence is causing measurable skill erosion among professionals. Polish physicians saw adenoma detection rates drop from 28.4% to 22.4% after using AI assistance, while software engineers using AI scored 17 percentage points lower on learning tests. The findings highlight growing concerns about AI deskilling across medicine and technology sectors.

Technology3 sources

AI Deskilling Emerges as Doctors and Programmers Lose Skills Through Over-Reliance on AI Tools

Technology3 sources

Deep learning identifies promising antibiotic candidates against drug-resistant gonorrhea

Researchers at Harvard's Wyss Institute used deep learning to screen 6 million compounds and identified two promising candidates against multi-drug resistant Neisseria gonorrhoeae. The lead compound, called A1, targets alanine racemase, an enzyme critical for bacterial cell wall formation. The study marks the first use of Organ Chip technology for antibiotic preclinical testing, offering a faster validation pipeline.

Science2 sources

Deep learning identifies promising antibiotic candidates against drug-resistant gonorrhea

Science2 sources

Midjourney Scanner promises MRI-quality scans in 60 seconds, but lacks FDA approval

Midjourney, the AI image generator company, unveiled its first hardware product: a full-body scanner using ultrasound technology that claims to deliver MRI-comparable results in about 60 seconds. CEO David Holz revealed plans for Midjourney Medical and a San Francisco spa housing the scanners. However, the device currently lacks FDA clearance and has no proven track record in medical diagnostics.

Health8 sources

Midjourney Scanner promises MRI-quality scans in 60 seconds, but lacks FDA approval

Health8 sources

Prev12 3 4…10 Next